WB
CPRX

WesBanco Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

WesBanco Bank’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96M Buy
79,000
+23,000
+41% +$548K 0.05% 244
2025
Q4 		$1.31M Hold
56,000
– – 0.04% 324
2025
Q3 		$1.1M Hold
56,000
– – 0.03% 351
2025
Q2 		$1.22M Buy
56,000
+37,000
+195% +$873K 0.04% 332
2025
Q1 		$461K Buy
+19,000
New +$428K 0.02% 447

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

WesBanco Bank's CPRX Position: Q1 2026 in Review

WesBanco Bank increased its Catalyst Pharmaceutical (CPRX) stake by 41% in Q1 2026, buying an estimated $548K and bringing the position to 79,000 shares worth $1.96M. The position accounts for 0.05% of the portfolio, ranked #244.

WesBanco Bank first reported a position in CPRX in Q1 2025 and has held it in 5 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • WesBanco Bank held 79,000 shares of Catalyst Pharmaceutical worth $1.96M as of Q1 2026.
  • WesBanco Bank bought 23,000 Catalyst Pharmaceutical shares in Q1 2026, an estimated $548K.
  • Catalyst Pharmaceutical made up 0.05% of WesBanco Bank's portfolio in Q1 2026, its #244 holding.
  • WesBanco Bank first reported a position in Catalyst Pharmaceutical in Q1 2025 and has held it in 5 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on WesBanco Bank's 13F filing for Q1 2026, filed 21 Apr 2026.